All Databases (4)
Recent SearchesRecent Searches
Selected ItemsSelected Items
Display selected items
Please select one or more items.
Close
My Research and Language SelectionMy Research
About ProQuest
Support Center

Access provided by
Universidad de El Salvador

Recent Searches
Selected Items
Display selected items
Please select one or more items.
Close
My Research and Language Selection
Help and support

Search ProQuest...

Select language

العربية
Bahasa Indonesia
Čeština
Deutsch
Español
Français
한국어
Italiano
Magyar
日本語
Norsk
Polski
Português (Brasil)
Português (Portugal)
Русский
ไทย
Türkçe
中文(简体)‎
中文(繁體)‎

Sign in to My Research

Save and organize your research.

Username:

Password:

Forgot your password?

Create My Research account

Exit

Would you like to exit ProQuest or continue working? Tab through to the exit button or continue working link.Help icon>

Exit ProQuest, or continue working?

Exit Continue working

Note: Items you have selected during your session and your list of recent searches are not saved unless you have signed into your account and added them to My Research.

Your session is about to expire

Your session is about to expire. Sessions expire after 30 minutes of inactivity. Tab through the options to the continue working button or end session link.

Help icon

Close icon Close icon

Your session will expire in .

Sessions expire after 30 minutes of inactivity.

Continue working End Session

Note: Items you have selected during your session and your list of recent searches are not saved unless you have signed into your account and added them to My Research.

Full Text
Scholarly Journal

Therapeutic response and safety of radioligand therapy with ¹⁷⁷Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients

Ashfaq, Wardah

; Rehman, Khurram

; Shahid, Abubaker

; Younis, Muhammad Numair

. Medical Oncology

; Middlesex Vol. 41, Iss. 9, (Sep 2024): 226. DOI:10.1007/s12032-024-02466-7

PDFDownload PDF CiteCite

Copy URL

https://www.proquest.com/scholarly-journals/therapeutic-response-safety-radioligand-therapy/docview/3092502672/se-2?accountid=208611

Print All Options

No items selected

Please select one or more items.

Select results items first to use the cite, email, save, and export options

Document Section options

Current viewPDF
Abstract/Details
30References
156With shared references
View on Web of Science
More

It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader

Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients

Therapeutic response and safety of radioligand therapy with ¹⁷⁷Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients